アクセス数 : ?
ダウンロード数 : ?
ID 115290
著者
板東, 浩 Tokushima University|Japan Low Carbohydrate Diet Promotion Association KAKEN研究者をさがす
キーワード
Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD) study
Canagliflozin cardioVascular Assessment Study (CANVAS)
Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure (DAPA-HF) study
The Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients-Removing Excess Glucose (EMPA-REG OUTCOME) study
sodium–glucose cotransporter 2 (SGLT2) inhibitors
資料タイプ
学術雑誌論文
抄録
Patients with diabetes and heart failure have been increasing due to Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD) study. β-blockers showed significantly suppressed cardiovascular events in the strict glycemic control group. Sodium-glucose Cotransporter-2 Inhibitors (SGLT2i) seem to be beneficial for diabetes and heart failure. Clinical efficacy of β-blockers would be suggested from three studies including Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients-Removing Excess Glucose (EMPA-REG OUTCOME) trial, Canagliflozin cardioVascular Assessment Study (CANVAS) and Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure (DAPA-HF) study. Further discussion will be expected with research in detail.
掲載誌名
Endocrinology & Metabolism International Journal
ISSN
24730815
出版者
MedCrave Publishing
8
4
開始ページ
97
終了ページ
99
発行日
2020-08-31
権利情報
©2020 Bando. This is an open access article distributed under the terms of the Creative Commons Attribution License(https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and build upon your work non-commercially.
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
医学系